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Many of the mechanisms proposed to explain proliferating or helper T  lymphocyte 
recognition of exogenous antigens are predicted on the four following basic observa- 
tions:  (a) soluble antigen alone fails to stimulate T  cells (1);  (b) antigen-specific T  cell 
stimulation depends on accessory cells, which in the guinea pig are macrophage-like 
(1-3);  (c) T  cell stimulation is genetically restricted for the Ia antigens expressed by 
the accessory cell  (4-9);  and  (d)  Ir gene function  is correlated with Ia expression by 
accessory cells  (10-14).  The  various  hypotheses accommodating  these  observations 
seem to fall into two general categories. The first category encompasses determinant 
selection-type proposals (15-17). For antigens not under Ir gene control, determinant 
selection  suggests  that  accessory  cell  Ia  antigens  bind  exogenous  antigen,  where 
different Ia species bind different antigenic regions, and that T  cells express a single 
antigen-combining receptor that interacts with distinct antigenic determinants of the 
exogenous antigen.  For antigens  under  Ir gene control,  the nonresponder accessory 
cell Ia fails to bind the antigen and/or there are no T cell antigen-combining receptors 
for those particular antigenic determinants.  The second category of proposals for T 
cell recognition are of the dual recognition type (18-20).  These mechanisms suggest 
that exogenous antigens need not bind to accessory cell Ia antigens, and that T  cells 
express two distinct receptors for recognition; one directed against Ia antigens, and a 
second directed against exogenous antigenic determinants. For antigens under Ir gene 
control,  T  cells  exhibit  allelic  exclusion  such  that  the  antigen-specific  receptor  is 
expressed  concordantly  only  with  structures  directed  against  Ia  of the  responder 
haplotype. 
One approach to examine the nature of T  cell recognition in light of these theories 
is to use small well defined peptide antigens to determine which regions of the antigen 
interact with T  cells and which regions, if any, specifically interact with accessory cell 
Ia. Initial studies using this approach have employed the  14 residue peptide antigen, 
* Supported in part by U.S. Public Health Service grant AI-14226 from the National Institute of Allergy 
and Infectious Diseases and HL-22642 from the National Heart, Lung, and Blood Institute, National 
Institutes of Health, 
:1: Recipient of Research Career Development Award AI-00352 from the National Institute of Allergy 
and Infectious  Diseases, National Institutes of Health. 
620  J. Exp. MED. © The Rockefeller  University Press • 0022-1007/80/09/0620/13 $1.00 
Volume 152  September  1980  620-632 THOMAS,  HSIEH, SCHAUSTER, MUDD, AND WILNER  621 
human  fibrinopeptide  B  (hFPB), x in  guinea  pig T  cell-proliferative responses.  We 
have previously found  that  strain  2  guinea pigs responded  to hFPB  (Bill-14),  that 
most of the antigenic regions were in the B/35-14  fragment, and that the minimum 
antigenic  and  immunogenic  fragment was B/~7-14  (21).  However, strain  2  animals 
failed to produce immune responses with the des-Arg hFPB homologue B~l-13.  By 
contrast,  strain  13  guinea pigs produced  immune responses with  B/~I-13, but  were 
unresponsive with B/~l-14.  Thus, genetic control of T  cell responsiveness to hFPB is 
determined by a single residue, Arg  14, and is regulated by Ia antigens of the stimulator 
macrophages (17). In this communication we examined the contributions of individual 
residues  in  the hFPB  homologue B/~5-14  (the peptide fragment containing  most of 
the antigenic regions involved in T  cell responses)  to T  cell responses using various 
synthetic analogues with single residue substitutions.  Several residues were identified 
that determined the specificity of the T  cell responses, and most likely serve as contact 
points  for a  clonally  distributed  T  cell  antigen-combining  receptor.  Several  other 
residues were identified that appear to serve as contact points for structures with more 
conservative combining properties. 
Materials and Methods 
Animals.  Inbred strain 2 and strain 13 guinea pigs were obtained from Biological Systems, 
Toms River, N. J. 
Antigens.  Human  fibrinopeptide  B  (hFPB,  B/31-14) was  purchased  from  Bachem,  Inc., 
Torrance, Calif., and purified protein derivative of tuberculin (PPD) from Connaught Medical 
Research Laboratory, Willowdale,  Ontario, Canada. 
Reagents.  All chemicals were of reagent grade. N~-tert-butoxycarbonyl (Boe) amino acids 
were  purchased  from  Baehem,  Inc.  Boc  amino  acids  with  protected  side  chains  were  13- 
benzylaspartic acid, ,/-benzylglutamic acid,  O-benzylserine,  Ng-tosylarginine,  and Ne-trifluo  - 
roacetyl lysine. All Boc amino acids were of the L-configuration  with the exception of glycine. 
Purity  of Boc  amino  acids  was  assessed  by  melting  points  (uncorrected)  and  thin-layer 
chromatography. DEAE-Sephacel and SP-Sephadex C-25 were obtained from Pharmacia Fine 
Chemicals, Div. of Pharmacia Inc., Piscataway, N. J. Bio-Gel P2, 100-200 mesh, was purchased 
from Bio-Rad Laboratories, Richmond, Calif. 
Peptide Synthesis.  Analogues  of human fibrinogen sequence  B~5-14 were synthesized  man- 
ually using Merrifield's solid-phase  method as previously described  (22). Boc-Asp and Boc-Gln 
were introduced using a N,N'-dicyclohexylcarbodiimide coupling in the presence of equimolar 
1-hydroxybenzotriazolemonohydrate. The analogue Arg  x4 ~  Lys was prepared by treating the 
analogue Arg  14 ---* Lys (Tfa) with 1 M piperidine to remove the TFA-blocking group (23). All 
analogues with the exception of Arg  TM ~  Lys (Tfa) were purified definitively by ion-exchange 
chromatography on  a  1.2- ×  34-cm  DEAE-Sephacel column equilibrated  with  a  0.005  M 
borate buffer (24) followed by desalting on a  2.0-×  70-era Bio-Gel P-2 column equilibrated 
with 0.05 M  NH4HCO3.  Analogue Arg  14 ---* Lys (Tfa)  was purified on a  1.2- ×  68-cm  SP- 
Sephadex C-25 column using a pH gradient as described before (22). Purity and identity of 
synthetic peptides were assessed by thin-layer chromatography, thin-layer electrophoresis,  and 
amino acid analysis (22, 24). 
Preparation  of Cells.  2-6 wk after immunization  with  400  #g of hFPB  or of the  various 
analogues in complete Freund's adjuvant (Difco Laboratories, Detroit, Mich.)  guinea pigs were 
injected intraperitoneally with 25 ml of sterile mineral oil (Marcol 52; Exxon Company, U. S. 
A.,  Houston,  Tex.),  and  the  resulting  peritoneal  exudate  was  harvested  3-4  d  later.  A  T 
lymphocyte-enriched peritoneal exudate lymphocyte (PEL) population was prepared by passing 
cells over a rayon wool adherence column (3). 
I Abbreviations used in  this paper."  BOC, Na-tert-butoxycarbonyl; DNP, dinitrophenyl; hFPB, human 
fibrinopeptide B; aH-TdR-[aH]methyl  thymidine; PEL, peritoneal exudate lymphocyte; PPD, purified 
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In Vitro Assay of DNA Synthesis.  Immune PEL (3-4 X  10  ~ cells/well)  were cultured in round- 
bottom  microtiter  plates  (Cooke  Laboratory  Products  Div.,  Dynatech  Laboratories,  Inc., 
Dynateeh Corp., Arlington, Va.) with soluble hFPB or the Bf15-14 analogues (5-40/~g/well)  or 
PPD (10 #g/well), in a total volume of 0.2 ml or RPMI-1640 medium (Grand Island Biological 
Co.,  Grand  Island,  N.  Y.)  containing  L-glutamine  (300 /~g/ml)  penicillin  (100 U/ml),  2- 
mercaptoethanol  (5  ×  10  -~ M),  and  5%  heat-inactivated  normal  guinea  pig serum.  After 
incubation for 2 d at 37°C  in 5% CO2 in air, 1 ffCi of tritiated thymidine (3H-TdR; sp act 6.7 
Ci/mmol; Research Products International Corp., Elk Grove Village,  Ill.) was added to each 
well. The amount of radioactivity incorporated into cellular DNA was determined after an 
additional 18-h incubation with the aid ofa semiautomated microharvesting device (Titer-Tek; 
Flow Laboratories, Inc., Rockville, Md.). Each 3H-TdR counts per minute value represents  the 
mean of triplicate cultures,  and the standard error was always within  10% of the mean. The 
representative experiments shown  were each performed two to six times with similar results, 
and 40/~g of the peptide antigens was the dose producing the highest  proliferative responses. 
Results 
To  examine  the  contributions  of  individual  residues  to  the  antigenicity  and 
immunogenicity  of hFPB,  various  analogues  of B/~5-14  were  synthesized  as  listed 
under  Fig.  1.  The  three  following  different  regions  of  the  Bf15-14  peptide  were 
investigated:  the basic residue  arginine  TM,  the hydrophobic residues  phenylalanine 1° 
and  phenylalanine u,  and  the  acidic  residues  aspartic  acid  5,  glutamic  acid  7,  and 
glutamic  acid  s.  Each  analogue  was  tested  for  antigenicity  by culture  with  hFPB- 
immune strain 2 guinea pig T  cells. In addition, strain 2 and strain  13 animals were 
immunized with each analogue and T  cell responsiveness determined by culture with 
the homologous analogue used for immunization, as well as Bill-14. 
Substitutions for Arginine 14.  The basic residue Arg  TM was replaced with another basic 
residue, lysine, or the ~-blocked neutral Lys (Tfa), and these analogues were examined 
for antigenieity and immunogenicity (Table I). T  cells from hFPB  strain 2 animals 
showed proliferative responses to Bill-14 and  5-14,  but were unresponsive to either 
the B~5-14 Lys  TM or Lys(Tfa)  TM analogues (Table I, lines 1 and 2). By contrast, T  cells 
from strain 2 guinea pigs immunized with the Lys  TM analogue responded to the Lys  TM 
analogue, but showed no responses to either Bfl 1-14 or the Lys(Tfa)14 analogue (Table 
I,  line  3).  In  similar  fashion,  T  cells  from  strain  2  animals  immunized  with  the 
Lys(Tfa)  TM analogue responded to the Lys(Tfa)  TM analogue, but were unresponsive to 
Bill-14 and 85-14, and showed a low response to the Lys  TM analogue (Table I, line 4). 
B~5-14 
AntiBenici ty  Immunogenicitt](_ 
for  hFPB-immune  Guinea Pig 
5  6  7  8  9  lO  II  12  13  14  Strain  2 T cells  Strain  2  Strain  13 
H2N-Asp-Asn-Glu-Glu-Gly-Phe-Phe-Ser-Ala-Arg-OH  +++  +++ 
Lys  +++ 
Lys(Tfa)  +++ 
Asn 
Gln-Gln 
Tyr. 
Phe(4-N02)____ 
Tyr 
Phe(4-N02) __ 
+++ 
+++ 
+++  +++ 
FIc.  1.  Primary structure of B~5-14 and B~5-14 analogues,  and summary of antigenicity and 
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TABLE  I 
Antigenicity and Immunogenicity of Analogues Containing Substitutions  for Arginine 14 
623 
Antigen in culture 
Guinea  Immunization  Bfl5-14 
pig  None  PPD  Bill-14  Bf15-14  Bf15-14  Argl4 
Arg  14 --', Lys  Lys(Tfa) 
Strain 2  Bill-14  1,452  1031490  37~107 
Strain 2  Bill-14  1,708  711919  28~583 
Strain 2  Bf15-14 
Arg  14 --~ Lys  2,290  761425  3,269 
Strain 2  Bfl5-14 
Arg  14 ~  Lys(Tfa)  1,301  881553  1,394 
Strain 13  Bfl5-14 
Arg  TM "* Lys  1,461  65~646  1,682 
Strain 13  Bfl5-14 
Arg  TM ---* Lys(Tfa)  2,612  471566  1,005 
nil_ TdR cpm 
21~918  1,656 
1,786 
21,875  4,007 
823  7,_7_9_3  26,341 
1,556  1,384 
2,409 
Strain 2 and strain  13 guinea  pigs were immunized  with  hFPB  (Bill-14) or the Bf15-14 analogues  as 
indicated in the Table. 2-6 wk after immunization T cell-enriched PEL were cultured in vitro with PPD, 
as a positive control, and Bill-14,  BflS-14, and the Bf15-14 analogues  (40 #g/well)  as described under 
Materials and Methods. The ZH-TdR counts per minute were determined on the 3rd d of culture,  and 
each value represents the mean counts  per minute from triplicate cultures.  Underlined values indicate 
those cultures  in  which  positive stimulation  occurred,  whereas a  dashed line  indicates  those cultures 
showing relatively less stimulation. 
It  is  not  known  if the  small  response  of Lys(Tfa)t4-immune  T  cells  to  the  Lys  14 
analogue represents antigenic cross-reactivity or, rather, results from contamination 
of the blocked lysine peptide with small amounts of free lysine. In any case, it is clear 
that  most  of  the  strain  2  T  cell  responsiveness  is  uniquely  directed  against  the 
14  Lys(Tfa)  analogue. Neither of these analogues, however, was immunogenic for strain 
13 guinea pigs (Table I, lines 5 and 6). 
Substitutions for Phenylalanine.  In the first series of experiments, residues Phe 1° and 
Phe 11 in Bfl5-14 were replaced by tyrosine, and the antigenicity and immunogenicity 
of the Tyr  1° and Tyr  ax Bfl5-14 analogues were determined as described above (Table 
II). T  cells from hFPB-immune strain 2  animals showed no responsiveness to either 
the Tyr  t° or Tyr  11 analogues (Table II, line 1). On the other hand, T  cells from strain 
2  guinea  pigs  immunized  with  the  Tyr  1°  analogue  were  responsive  to  the  Tyr  1° 
analogue, but were unresponsive to the Tyr  11 analogue and showed low responses to 
Bill-14  and  5-14  (Table  II,  line  2).  By  contrast,  T  cells  from  strain  2  animals 
immunized with the Tyr  n  analogue were unresponsive to all of the analogues tested 
(Table II, line 3). This lack of responsiveness did not seem to be a  result of dominant 
suppresssion because mixtures of the Tyr  11 analogue with  either hFPB  or the Tyr  1° 
analogue for immunization and in vitro challenge did not diminish responsiveness to 
hFPB or the Tyr  1° analogue, respectively (data not shown). The Tyr  1° analogue was 624  T  LYMPHOCYTE RECOGNITION OF SMALL PEPTIDE ANTIGENS 
TABLE II 
Antigenicity and Immunogenicity of Analogues m which Phenylalanine to and Phenylalanine 11 Are Replaced 
by Tyrosine 
Guinea  Immunization  pig 
Antigen in Culture 
None  PPD  Bill-14  BB5-14  BflS-14  Bf15-14 
Phe t° ~  Tyr  Phe  II ~  Tyr 
"~  H- TdR cpm 
Strain 2  Bill-14  1,416  151~730  17~334  111508  1,876  1,726 
Strain 2  Bfl5-14 
Phe  1° ---* Tyr  2,030  153,637  15a730  -  10.~5_82  111,690  3,410 
Strain 2  Bf15-14 
Phe  11 --* Tyr  2,898  178,955  3,929  3,892  3,563  3,724 
Strain 13  Bfl5-14 
Phe  ~° ~  Tyr  4,993  181~983  4,850  4,366  6,748  4,114 
Strain 13  Bfl5-14 
Phe  11 --* Tyr  3,893  248~827  4,043  4,412  4,885  8,652 
See legend for Table I. 
not immunogenic for strain  13 guinea pigs, as found for the residue  14 analogues, but 
T  cells  from strain  13  animals  immunized with  the Tyr  11  analogue showed  a  low 
response to the Tyr  al analogue (Table II, lines 4 and 5). 
In a second series of experiments, residues Phe  1° and Phe  11 were replaced by Phe(4- 
NO2), and the Phe(4-NOz) 1° and Phe(4-NO2) 11 Bfl5-14 analogues were examined for 
antigenicity and immunogenicity as before. The patterns ofT cell responsiveness were 
essentially identical with those observed with the Tyr  l° and Tyr  al analogues. Briefly, 
neither  the  Phe(4-NOz) l°  nor  Phe(4-NOz) xl  analogues  stimulated  hFPB-immune 
strain 2 T  cells (Table III, line 1). Strain 2 animals immunized with the Phe(4-NOz) 1° 
analogue responded to the Phe(4-NO2) 1° analogue but not to Bill-14 or to the Phe(4- 
NO2) 11 analogue (Table III, line 2), and the Phe(4-NOz) 11 analogue was nonimmu- 
nogenic for strain 2 guinea pigs (Table III, line 3). Neither analogue was immunogenic 
for strain  13 animals (Table III, lines 4 and 5). Again, mixtures of the Phe(4-NO2) 11 
analogue with hFPB for immunization and in vitro challenge did not diminish the 
hFPB-specific strain 2 T  cell responses (data not shown). 
Substitutions for  Glutamic  Acid.  To examine the contribution of residues  Glu 7 and 
Glu  8  to  T  cell  responses  to  hFPB  both  of  these  residues  were  substituted  with 
glutamine,  and  the  antigenicity  and  immunogenicity  of the  Gln  7,s  Bf15-14  were 
analogue determined.  T  cells  from hFPB-immune strain  2  animals  respond  to  the 
Gin  7'a analogue at levels  from 20 to 30% of the response observed to Bill-14  (Table 
IV, line  1). By contrast, T  cells  from strain 2 guinea pigs immunized with the Gin  7'8 
analogue responded poorly to the Gln  7,a analogue, but showed good responses to Bill- 
14,  BflS-14,  and  7-14  (Table IV, line 2).  This pattern  of responsiveness after Gin  7's 
analogue immunization has been consistent in five different experiments. In addition, 
mixtures of the Gln  7,a analogue with hFPB for immunization and in vitro challenge THOMAS,  HSIEH,  SCHAUSTER, MUDD,  AND WILNER  625 
TABLE III 
Antigenicity and Immunogenicity  of Analogues  in which Residues  Phenylalanine w and Phenylalanine tt Are 
Replaced by Phenylalanine  (4-NOe) 
Antigen in culture 
Guinea  Immunization  Bf15-14  Bfl5-14 
pig  None  PPD  Bill-14  Phe I° --*  Phe  n 
Phe (4-NO2) Phe (4-NO2) 
3  H_ TdR cpm 
Strain 2  Bill-14  2,452  571927  52,228  3,772  2,852 
Strain 2  Bf15-14 
Phe  TM ---* Phe(4-NO2)  2,418  501262  1,862  291644  1,909 
Strain 2  Bfl5-14 
Phe  n ---* Phe(4-NO2)  4,859  1541400  4,399  3,529  3,662 
Strain 13  Bf15-14 
Phel° ---* Phe(4-NO2)  1,164  148,983  2,036  1,570  t,874 
Strain 13  Bf15-14 
Phe  I1 ---, Phe(4-NO2)  702  721066  519  676  979 
See legend for Table I. 
TASL~ IV 
Antigenicity and lmmunogenicity  of an Analogue  in which Glutamic Acid 7 and Glutamic Acid s Are 
Replaced by Glutamine 
Guinea  Immunization  pig 
Antigen in culture 
None  PPD  Bill-14  Bf15-14  Bf17-14  Bf15-14  GluV,S.---~Gln 
Strain 2 
Strain 2 
3  H_ TdR cpm 
Bill-14  5,020  98,322  36,677  11~645 
BB5-14 
GIn  7,a ~  Gin  3,063  133~291  431576  481935  37,323  _6,967 
Strain 13  Bfl5-14 
Glu  7'a ~  Gin  1,077  1441946  879  1,038 
See legend for Table I. 
did  not alter the magnitude or pattern of T  cell responsiveness to  hFPB or to  the 
Gin  7's analogue (data not shown). As was found for the other analogues tested, strain 
13 guinea pigs failed to respond to the Gin  7'a analogue (Table IV, line 3). 
Substitution for Aspartic Acid.  The contribution of residue Asp  5 to T  cell responses 
was  examined  by  replacing  Asp  5  with  asparagine  (Table  V).  The  Asn  5  Bfl5-14 
analogue stimulated hFPB-immune strain 2  T  cells to  around half of the  response 
observed with Bill-14 and 80% of that observed with Bfl5-14 (Table V, line 1). T  cells 
from  strain  2  animals immunized with  the  Asn  5 analogue  produced  proliferative 626  T  LYMPHOCYTE RECOGNITION OF  SMALL PEPTIDE ANTIGENS 
TABLE V 
Antigenicity and Immunogenicity  of an Analogue  in which Aspartic Acid 5 is Replaced with Asparagine 
Guinea  Immunization  pig 
Antigen in culture 
None  PPD  Bfl 1  - 14  Bfl5-14  Bfl5-14  Asp  5  --~ Asn 
3H-TdR cpm 
Strain 2  Bill-14  2,952  121~801  47~254  337117  26~865 
Strain 2  Bfl5-14 
Asp  5  --* Asn  2,366  85~399  462437  477302  56~661 
Strain 13  Bf15-14 
Asp  ~  --* Asn  2,780  103~960  1,280  1,162 
See legend for Table I. 
responses to the Asn  5 analogue that were slightly greater than the responses observed 
with Bill-14 and 5-14 (Table V, line 2). Again strain  13 guinea pigs failed to respond 
to the Asn  ~ analogue (Table V, line 3). 
Discussion 
In the present study we examined the involvement of individual residues of hFPB 
in guinea pig T  cell-proliferative responses by using synthetic analogues containing 
residue  substitutions.  A  summary of T  cell  responsiveness to the hFPB  homologue 
Bf15-14  and various Bf15-14  analogues is shown in Fig.  1.  Substitutions  for residues 
14,  ll,  and  10  totally  eliminate  antigenicity  for  hFPB-immune  strain  2  T  cells, 
whereas substitutions for residues 7, 8, and 5 retain antigenicity. These results suggest 
that  the COOH-terminal  region  of the  Bfl5-14 molecule is more critical  for T  cell 
responsiveness than the NH2-terminal region. However, as based on immunogenicity, 
the  residues  seem to play different  roles  in  T  cell responses.  Analogues containing 
substitutions  for residues  14 and  10 are immunogenic for strain 2 animals and elicit 
specific  T  cell  responses  that  are  noncross-reactive  with  the  Bfl5-14  peptide.  By 
contrast, analogues with substitutions for residues  11 and 7 and 8 are non- or poorly 
immunogenic, respectively, as based on in vitro T  cell responses to the homologous 
antigen.  Thus,  it  would  appear  that  the  residue  substitutions  fall  into  two  broad 
categories: (a) substitutions that create new immunogenic and antigenic determinants; 
and  (b)  substitutions  that  destroy or alter the  immunogenicity of the peptide.  It is 
likely that these substitutions define at least two different roles for residues in T  cell 
responses to the BflS-14 antigen, as will be discussed below. 
Substitutions for Arginine t4 and Phenylalanine 1o.  Some of the most striking observations 
ofT cell responses to the various Bfl5-14 analogues is that substitutions for residues 14 
and  10 create distinct  antigenic specificities.  Replacement of Arg  TM  in  Bfl5-14 with 
either  intact  or  blocked  lysine  results  in  analogues  with  unique  noncross-reactive 
antigenic determinants.  In similar fashion, replacing Phe 1° with Tyr or Phe(4-NO2) 
produced  unique  T  cell  responses  specific  for  the  substituted  residues.  It  is  clear, 
therefore, that residues 10 and 14 are responsible for the antigenic specificity of the T 
cell responses to Bf15-14.  In addition,  the T  cell responses elicited  by each of these THOMAS, HSIEH, SCHAUSTER, MUDD, AND WILNER  627 
residue  10  and  14  analogues  seem  to  be highly  specific  for the  side  chain  of that 
residue, as shown schematically in Fig. 2. Thus, the T  cell responses can discriminate 
subtle parasubstitutions on the phenol ring of Phe 1°, and in alterations of the amino 
group of residue  14. These substitutions clearly indicate that the antigenic specificity 
of the  T  cell  responses  to  the  B~5-14  analogues  is  determined  primarily  by  the 
configuration of the side chains of residues  10 and  14.  For this reason, the preferred 
conformation of these peptide antigens in solution does not seem to be critical for the 
specificity of the  T  cell  responses  as suggested by others  for protein  antigens  (25), 
although it cannot be ruled out that conformation has other roles in antigenicity of 
these small peptides. 
Because each residue  10 and  14 substitution elicits distinct T  cell clones in strain 2 
guinea pigs, the simplest explanation  is that these residues serve as contact residues 
for clonally distributed T  cell receptors. If the observed clonal selection resided with 
macrophages,  then  macrophages  must  exhibit  highly  specific  antigen-combining 
structures, and each of these must specifically interact with different T  cell subpopu- 
lations,  all of which  express similar antigen-specific receptors. The most likely mac- 
rophage structures with these properties may be Ia antigens. However, the number of 
I  (c~2)j  k..  R,c,p,o, 
C~2 
i  COOH  B~-~4  H2N -  10  14 
~'14  H2N  ~  114 COOH  Argld~Lys 
Csz  (CH2)  4 
ap5-14  .~.  /0  ~  coo. 
ArO  t4- l.y, (Tfo) 
~p5-14  H2  N  I  I  COOH 
PhelO phe (4.N02)  10  T4 
0ps-w4  .2N  ~0  ~  COO. 
Ph*  10~ T),, 
Fie.  2.  Representation of the specificity of T  lymphocyte responses  for the side chains of residues 
10 and 14. Each structure is a umque" antigenic species specific.  .f°r14parasubstituti°ns. of phenylala- 
nine  1° (4-OH, or 4-NO2), or alterations of the ~-amine  of argmme  (lysme,  or lysine [Tfa] with a 
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residue  10 and 14 analogues tested thus far (five) already exceeds the number of strain 
2 guinea pig Ia specificities (two) showing limited heterogeneity (26).  Therefore, we 
favor the interpretation  that Arg  14 and Phe ~° serve as contact residues for strain 2 T 
cell antigen-combining receptors. As observed with the analogues tested thus far, the 
clonally distributed  T  cell receptor may contain  a  minimum of two hypervariable- 
like regions allowing specific interactions with residues 14 and 10. Thus, either one of 
these  residues  can  be kept  constant  while  replacing  the  other  residue  to  select  for 
distinct T  cell clones. 
Substitution for Phenylalanine 11.  By contrast with the roles of residues  14 and  10 as 
discussed  above, replacement of Phe 11 with Tyr or Phe(4-NO2)  completely destroys 
the immunogenicity of the Bf15-14 analogues. This is particularly intriguing because 
the same substitutions for Phe ~° created unique immunogenic analogues. It is also of 
interest to note that a rabbit anti-hFPB antibody directed against the Bf15-14 region 
of hFPB bound the Bf15-14, Tyr  n  analogue to the same extent as Bf15-14,  indicating 
that  the Tyr  n  substitution  does not  radically alter the antigen,  and  that  there are 
differences in recognition of the same antigenic region by rabbit antibody and guinea 
pig  T  cells  (D.  W.  Thomas  and  G.  D.  Wilner.  Unpublished  observations.).  Two 
explanations for the observations that alterations of residue  11 destroy immunogenic- 
ity for T  cell responses are:  (a) Tyr or Phe(4-NO2) substitutions add bulk to the Phe it 
side chain that make these analogues too big to fit within  the spacial constraints of 
the antigen-combining pocket; or (b) residue  11  serves as a contact residue for more 
conservative antigen-combining regions of cellular receptors. The cellular expression 
of this  receptor could  reside with either T  cells or macrophages. These possibilities 
will be examined by constructing a series of residue  11 analogues with side chains of 
varying sizes. 
Substitution for Glutamic  Acid,  Replacing  residues  Glu 7 and  Glu  s  with  glutamine 
creates  an  analogue  that  behaves  like  the  Phen-substituted  analogues  in  that  the 
Gin  7's analogue is poorly immunogenic. However, one important difference is that the 
Gin  7's analogue primes strain 2 T  cells for subsequent  responses to Bill-14, 5-14 and 
7-14.  Clearly, the Gln  v's analogue retains the antigenic determinants responsible for 
T  cell priming, but itself only poorly stimulates those T  cells in vitro. Thus, residues 
Glu  7 and Glu  s are not involved in the specificity of T  cell responses, but nonetheless 
provide a role in T  cell stimulation. These findings suggest that antigen presentation 
may be more restricted  for the Gin analogue,  rather than  interference with  T  cell 
recognition  of  the  antigenic  determinants  per  se.  For  this  reason,  we  favor  the 
explanation  that  Glu v and/or  Glu  s  may be important  for antigen  presentation  by 
accessory cells. Again, analogues with a variety of substitutions for glutamic acid will 
allow determination of the specificity and chemical requirements for the function of 
these residues. 
Substitution for Aspartic  Acid.  All  of the  residues  discussed  above appear to serve 
important  functions in strain  2 guinea pig T  cell responses to hFPB.  Residue Asp  5, 
however, seems to be less  important  in  its contribution  to T  cell responses because 
replacement with asparagine does not markedly alter the Bf15-14 antigen.  Thus, the 
Ash  5 analogue retains antigenicity  for in  vitro hFPB-immune T  cell responses, and 
primes strain  2  animals for T  cell  responses  to hFPB.  This result  is  not  surprising 
because we previously found that the major antigenic region of hFPB was contained 
in the Bf17-14 homologue with only minor contributions by the rest of the peptide. 2 
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Genetic Control and  T  Lymphocyte Recognition.  We  previously  found  that  genetic 
control of T  cell responsiveness to hFPB was determined solely by the presence or 
absence of Arg14; strain 2 guinea pigs required Arg  x4, and strain 13 animals responded 
to only the des-Arg homologue (21). In addition, we found that this Ir gene function 
corresponded with  Ia  antigen  expression by antigen-presenting  macrophages  (17). 
Initially, we thought that this Ir gene function was a property of Arg  14 itself because 
strain 2 guinea pigs are known to respond to basic antigens such as poly-L-lysine and 
poly-L-arginine (27).  Therefore it  was  anticipated  that  neutralization of the  basic 
charge of residue 14, as with the blocked lysine group, may abrogate Ir gene function. 
This was not observed because strain 2 animals responded to the Lys(Tfa) analogue, 
whereas  strain  13  guinea  pigs  remained  nonresponders.  In  fact, strain  13  animals 
failed to respond well to any of the B~5-14 analogues examined thu~ far. It would 
therefore seem  that  the  presence of residues  in  position  14  irrespective of charge 
somehow prohibits strain 13 T cell responsiveness to these peptides. Thus, the peptide 
analogues tested thus far indicate that it is possible to alter completely the specificity 
of the strain 2 clonal T  cell response while preserving genetic control. Schlossman et 
al.  reached a  similar conclusion based on their elegant studies of cellular immune 
responses in guinea pigs to dinitrophenyl (DNP)-oligolysine antigens (28-31). In these 
studies, strain 2 animals responded to antigens as small as DNP-heptalysine and could 
distinguish between the length of the DNP-oligolysines antigens as well as the position 
of the DNP hapten. However, strain  13 animals remained unresponsive, demonstrat- 
ing that  it  is  possible  to  alter the specificity of the strain  2  T  cell response while 
retaining Ir gene control. An examination of the contribution of residues involved in 
strain 13 T  cell responses to des-Arg hFPB and further substitutions for residue 14 are 
critical for defining the mechanisms of Ir gene function in T cell responsiveness to the 
hFPB peptide antigens. 
To approach  an  understanding  of strain  2  guinea  pig T  cell recognition of the 
major antigenic determinant contained in residues 7-14 several observations must be 
considered:  (a)  there is an absolute requirement for Arga4;  (b) Arg  a4 determines the 
specificity of the T  cell response; and  (c) there is an absolute correlation for respon- 
siveness between Arg  ~4 and Ia antigen expression by strain 2 stimulator macrophages. 
These latter two observations initially seem discrepant because on the one hand, Arg  x4 
appears to be a contact residue for a T  cell receptor, and on the other hand is closely 
associated with macrophage Ia antigens. Taken together, these observations suggest 
that macrophage Ia antigens dictate or permit T  cell interaction with residue 14. The 
implication of this suggestion is that macrophage Ia antigens are intimately involved 
in  T  cell recognition of these peptide antigens.  One model to accommodate these 
observations is schematically shown in Fig. 3.  Basically, a  single antigen-combining 
T Lymohocyte  ~  Rec~ 
FiG. 3.  Schematic  representation  ofT lymphocyte  recognition  of the octapeptide antigen Bf17-14. 
A single antigen-combining  site is formed by the interaction  of a T cell receptor  with accessory  cell 
Ia antigens. Optimal binding  of  the peptide  within this site requires  contributions  by both structures; 
the T cell receptor  contacts residues Arg  ~4 and Phe  ~°, and Ia may contact other peptide residues. 630  T  LYMPHOCYTE  RECOGNITION  OF  SMALL  PEPTIDE  ANTIGENS 
pocket  is formed by an  interaction between stimulator or accessory cell Ia antigen 
and  the  T  cell  receptor,  perhaps  analogous  to  heavy-light  chain  combining  in 
antibodies. Constraints on antigen recognition are thereby imposed in part by both 
structures, and the residue and spatial accommodation of the antigen-combining site 
determine  responsiveness.  Based  on  T  cell  responses  to  DNP-oligolysine antigens, 
Stashenko and Schlossman  (31) similarly reasoned that the Ir gene may cooperate 
with  or  modify the  T  cell  antigen-combining receptor.  As  shown  for the  Bf17-14 
antigen, the T cell receptor probably contacts both Arg  a4 and Phe 1°, whereas accessory 
cell Ia may interact with other regions of the peptide, e.g., with Phe H and Glu  7's. The 
fine specificity of antigen responsiveness is therefore contributed by the hypervariable- 
like regions of the T  cell antigen-combining receptor. The Ia antigens may be much 
more  restricted  in  their  interaction  with  the  peptide  antigen  and  exhibit  limited 
antigen-combining specificities. According to this model, the minimum number of 
interactions required for antigen recognition by T  cells would be two; the first being 
the interaction between the T  cell receptor and Ia antigen to create the combining 
pocket,  and  the  second  is  the  binding of antigen  within  that  pocket.  Exogenous 
antigen may not bind well to either of these structures individually, or may be bound 
to Ia before T cell interactions, as suggested before (16). For alloreactivity, this model 
would predict a single interaction, the residues contacted by hypervariable-like regions 
of the T  cell receptor in this case being inherent in the allogeneic Ia as allelic residue 
substitutions. Obviously, resolution of this or other models of T  cell recognition will 
require isolation and biochemical characterization of the recognition complex. Never- 
theless, the approach presented here of using small peptide antigens to examine more 
carefully the specificity and antigenic requirements for T cell responses allows a better 
understanding of the recognition processes  involved, and provides insight into im- 
munocompetent cellular interactions and mechanisms for genetic regulation of im- 
mune responsiveness. 
Summary 
Guinea pig T lymphocyte responses to a decapeptide antigen (NH2-AspS-Asn6-Glu7- 
GluS-Glyg-Phel°-Phen-Ser12-Ala13-Arg14-OH)  of human fibrinopeptide B (hFPB) were 
examined using various synthetic peptide analogues containing single residue substi- 
tutions.  Each  analogue was  examined  for  antigenicity as  determined  by  in  vitro 
proliferative responses of hFPB-immune strain 2 guinea pig T cells. In addition, both 
strain 2 and strain  13 animals were immunized with each analogue and immunoge- 
nicity assessed  by in vitro T  cell-proliferative responses with the homologous immu- 
nizing analogue and the parent peptide. Replacement of arginine  14 with lysine formed 
an immunogenic analogue which showed no antigenic cross-reactivity with the native 
peptide in strain 2 T cell responses. In addition, substitution of arginine  TM with blocked 
lysine again  produced  a  unique  immunogenic analogue  that  showed  little  or  no 
antigenic identity with the intact lysine analogue or the native peptide.  In similar 
fashion, substitution of residue phenylalanine  1° with tyrosine or Phe(4-NO2)  created 
unique  immunogenic analogues  with  little  or  no  antigenic  identity to  the  native 
peptide with strain 2 T  cells. By contrast, replacement of phenylalanine  11 with either 
tyrosine or Phe(4-NO2) resulted in analogues with a total loss of immunogenicity and 
antigenicity in strain 2 T  cell responses. An analogue in which glutamic acid  7,s were 
replaced with glutamine retained a small degree of antigenicity with hFPB-immune THOMAS,  HSIEH, SGHAUSTER, MUDD, AND WILNER  631 
T  cells, but T  cells from strain 2 animals immunized with the Gin analogue responded 
only marginally to  the  Gin  analogue  while  producing  good  proliferative responses 
with the native peptide. On the other hand, an analogue in which asparatic acid  5 was 
replaced with asparagine retained most of the antigenic identity with hFPB for strain 
2 T  cell responses. None of these analogues were immunogenic for strain  13 guinea 
pigs.  These  observations  are  discussed  with  respect  to  the  contribution  of  each 
substituted residue to T  cell responses, mechanism of Ir gene function, and a  model 
for T  cell recognition of small peptide antigens. 
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